| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | LOMBARD MEDICAL INC | 1,275,779 | 995,000 | 1.10% | ||
| 2 | Catabasis Pharmaceuticals Inc | 2,857,667 | 4,572,000 | 5.05% | ||
| 3 | TRANSENTERIX INC | 7,546,692 | 9,131,000 | 10.08% | ||
| 4 | OCULAR THERAPEUTIX INC | 1,605,207 | 14,896,000 | 16.45% | ||
| 5 | KALVISTA PHARMACEUTICALS INC | 2,579,490 | 20,146,000 | 22.25% | ||
| 6 | ENTELLUS MED INC | 2,956,456 | 40,801,000 | 45.06% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0000950123-17-003684, filed 2017.05.01).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
